Kalydeco Side Effects May Increase Risk of Child Cataracts: FDA
Children taking the cystic fibrosis drug Kalydeco may face an increased risk of developing cataracts, according to federal drug regulators.
August 30, 2012 By: Irvin Jackson
Children taking the cystic fibrosis drug Kalydeco may face an increased risk of developing cataracts, according to federal drug regulators.
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.
A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.